drugset / Trial / NCT01114750

A Study to Determine the Absorption of Peroral Insulin in Dextran Matrix (ORA3)

NCT01114750

Phase 1 Suspended 8 enrolled Bows Pharmaceuticals AG
RandomizedCrossoverSingle-blindBasic science

Summary

A pharmacokinetic study on the absorption of perorally delivered insulin in dextran matrix after single dose administration.

Timeline

Start
2010-04
Primary completion
2010-08
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Protein / enzyme biologic 200 iu Oral

Indications